Drug Patent Expirations in June 2011

Drug Patent Expirations in June 2011

*Drugs may be covered by multiple patents



TradenameApplicantGeneric NamePatent NumberPatent Expiration
FEMARANovartis Pharmsletrozole4,978,672Jun 3, 2011
TAZORACAllergantazarotene5,089,509Jun 13, 2011
AVAGEAllergantazarotene5,089,509Jun 13, 2011
NUEDEXTAAvanir Pharmsdextromethorphan hydrobromide; quinidine sulfate5,166,207Jun 17, 2011
PATADAYAlconolopatadine hydrochloride5,116,863*PEDJun 18, 2011
PATANOLAlconolopatadine hydrochloride5,116,863*PEDJun 18, 2011
PATANASEAlconolopatadine hydrochloride5,116,863*PEDJun 18, 2011
LEVAQUINOrtho Mcneil Janssenlevofloxacin5,053,407*PEDJun 20, 2011
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINEROrtho Mcneil Pharmlevofloxacin5,053,407*PEDJun 20, 2011
LEVAQUINOrtho Mcneil Pharmlevofloxacin5,053,407*PEDJun 20, 2011
DILTIAZEM HYDROCHLORIDEBiovaildiltiazem hydrochloride5,288,505Jun 26, 2011
BAYCOLBayer Pharmscerivastatin sodium5,006,530Jun 26, 2011
CARDIZEM LABiovail Labs Intldiltiazem hydrochloride5,288,505Jun 26, 2011
COVERA-HSGd Searle Llcverapamil hydrochloride5,160,744Jun 27, 2011
COVERA-HSGd Searle Llcverapamil hydrochloride5,252,338Jun 27, 2011
ELIGARDTolmar Therapleuprolide acetate5,324,519Jun 28, 2011
LIPITORPfizeratorvastatin calciumRE40667*PEDJun 28, 2011
LIPITORPfizeratorvastatin calcium5,273,995*PEDJun 28, 2011
CADUETPfizeramlodipine besylate; atorvastatin calcium5,273,995*PEDJun 28, 2011
CADUETPfizeramlodipine besylate; atorvastatin calciumRE40667*PEDJun 28, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog